Filter by: Subject

Results Per Page:

Filter by: Subject

Acid-fast bacilli (AFB) (1)
Acquired immune deficiency syndrome (AIDS) (1)
Adults (1)
Anti-tuberculosis drugs (1)
BACTEC MGIT 960 (1)
Bedaquiline (1)
Bedaquiline (BDQ) (1)
Centre for Tuberculosis (CTB) (1)
Clofazimine (CFZ) (1)
Cut-off value (ECV) (1)
Detection system (1)
Drug resistance (2)
Epidemics (1)
Extensively drug-resistant tuberculosis (XDR-TB) (2)
Genetic sequencing (1)
Genome (1)
HIV/AIDS (1)
Human immunodeficiency virus (HIV) (4)
Infection (1)
KwaZulu-Natal, South Africa (1)
MDR-TB (1)
Microscopy (1)
Minimal inhibitory concentrations (MIC) (1)
Minimum inhibitory concentration (1)
Minimum inhibitory concentrations (MIC) (1)
Molecular detection (1)
Molecular epidemiology (1)
Molecular testing (1)
Multi-drug resistant tuberculosis (MDR-TB) (1)
Multi-drug-resistant (MDR) (1)
Multidrug resistance -- South Africa (1)
Multidrug resistant (MDR) (1)
Multidrug resistant tuberculosis (MDR-TB). (1)
Multidrug-resistant tuberculosis (MDR-TB) (1)
Mutation (1)
Mycobacterial culture (1)
Mycobacterium tuberculosis (1)
Mycobacterium tuberculosis (MTB) (1)
Mycobacterium tuberculosis complex (MTBC) (1)
Nontuberculous mycobacteria (NTM) (1)
Patients (1)
Point mutation (1)
Preservation (1)
Public health institution (1)
Resistance associated variant (RAV) (1)
Rifabutin (RFB) (1)
Rifampicin (1)
Rifampicin-resistant tuberculosis (1)
rpoB (1)
Single nucleotide polymorphism (1)
South Africa (SA) (3)
Specimen transport medium sputum (1)
TB diagnosis (1)
TBDx (1)
Transmission (2)
Triage (1)
Tuberculosis (TB) (13)
Tuberculosis -- Research -- South Africa (1)
Tuberculosis -- Treatment -- South Africa (1)
Whole-genome sequencing (WGS) (1)